AstraZeneca (AZN) Posts Light Q4 EPS Results; Revs Top Views
Tweet Send to a FriendGet Alerts AZN Hot Sheet
Trade AZN Now!
AstraZeneca (NYSE: AZN) reported Q4 EPS of $1.16, $0.40 worse than the analyst estimate of $1.56. Revenue for the quarter came in at $8.66 billion versus the consensus estimate of $8.59 billion.
For earnings history and earnings-related data on AstraZeneca (AZN) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on AstraZeneca (AZN) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Brady Corp. (BRC) Misses Q3 EPS by 5c; Guides Q4 EPS Below Views
- 21Vianet Group (VNET) Misses Q1 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
